Pharmacologic studies with triflubazam (ORF 8063): a new psychotherapeutic agent.
D000374:Aggression / Q000187:drug effects; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology* / Q000633:toxicity; D000927:Anticonvulsants / Q000494:pharmacology; D000932:Antiemetics / Q000494:pharmacology; D001067:Appetite Depressants / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D002415:Cats; D002707:Chlordiazepoxide / Q000494:pharmacology; D003975:Diazepam / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004435:Eating / Q000187:drug effects; D004597:Electroshock; D000431:Ethanol / Q000494:pharmacology; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006845:Hydrocarbons, Fluorinated / Q000494:pharmacology; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009048:Motor Skills / Q000187:drug effects; D009461:Neurologic Manifestations; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D012640:Seizures / Q000139:chemically induced; D013045:Species Specificity; D013997:Time Factors
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D000932:Antiemetics; D001067:Appetite Depressants; D006845:Hydrocarbons, Fluorinated; D006993:Hypnotics and Sedatives; D000431:Ethanol; D002707:Chlordiazepoxide; D003975:Diazepam; D010433:Pentylenetetrazole